Noom and Hims are two distinct telehealth platforms offering GLP-1 medication programs, each with different business models, clinical oversight structures, and personalization strategies.

Hims is a telemedicine platform offering branded and compounded GLP-1 medications like semaglutide. This review examines clinical evidence on telemedicine efficacy, cost structures, and how precision-focused compounding approaches compare for personalized weight management.

Hims and Hers are sibling brands run by one parent company, so the real question is why a single platform runs two front doors. This independent PlexusDx review examines the shared infrastructure, the branding split, the common medication pathway, and the biology that infrastructure leaves untouched.

Hims is a broad multi-category telehealth brand; Fridays is a focused weight program. This independent review compares how each structures its GLP-1 offer, what the pricing looks like, and the upstream genetic layer that neither platform maps before a prescription is written.

Hims and Ro run on nearly the same subscription-telehealth model, which makes the operational details the real deciding factors. This editorial overview shows how to compare two look-alike programs and adds the genetic context that outlasts any subscription you choose.

An independent editorial look at the Hims subscription model: how the recurring GLP-1 membership is structured, what a monthly charge actually covers, the pharmacy pathways involved, and the genetic context that sits upstream of any auto-renewing telehealth plan.

An independent editorial review of the Hims Wegovy question: what branded semaglutide means for a telehealth order, how branded Wegovy differs from compounded semaglutide, the STEP trial evidence, and the pathway-level genetic context no prescription reads.

This independent editorial review breaks down what drives the cost of a telehealth GLP-1 program like Hims — program fees, medication, branded versus compounded, and cash-pay reality — and contrasts it with transparent PlexusDx protocol pricing and genetic testing.

What does Hims actually cost each month, and what does that subscription buy? This independent review breaks the recurring charge into its parts, explains what drives the total in cash-pay compounded telehealth, and adds the genetic context most cost pages leave out.

Every legitimate way to get a GLP-1 prescription in New York in 2026 — telehealth, PCP, obesity specialist, NYC clinic — with verified cash-pay pricing, NYRx Medicaid exclusion details, and where PlexusDx Weight Management Protocols ($129–$309/mo) fit relative to Wegovy and Zepbound.

Hers accepts HSA/FSA via reimbursement (pay with regular card, submit receipt). PlexusDx accepts HSA/FSA card payment at checkout where your plan permits, with no membership fee — protocols from $129/mo, all 50 states.

Eight month-to-month GLP-1 providers compared against PlexusDx Weight Management Protocols on real annual cost, separate membership fees, intro-price cliffs, and genetic baseline. PlexusDx Microdose at $129/mo flat, Semaglutide Injection $189, Tirzepatide Injection $289, GLP-Squared $289 — all cash-pay, no membership.

Which Wegovy providers actually let you swipe your FSA card at checkout vs. file for reimbursement? NovoCare Pharmacy and LifeMD verified for direct-card payment; Hims, Hers, and Ro are reimbursement-first. Plus what to do when your FSA balance runs out and PlexusDx Semaglutide Injection at $189/mo month-to-month, or from $149/mo on the 6-month plan becomes the flat cash-pay reframe.

MEDVi, Hers, and PlexusDx price GLP-1 care three different ways: MEDVi with an introductory month and a recurring refill rate, Hers with a membership billed apart from branded medication, and PlexusDx with one flat monthly price. This comparison uses each company's own pages as of September 22, 2026 and keeps compounded and branded products separate.

Florida residents can legally start GLP-1 telehealth in days under Statute §456.47. We compare MEDVi, Ro, Walgreens, and the PlexusDx Microdose GLP-1 Protocol from $129/mo — with a genetic baseline option no other Florida provider offers.

A buyer-side read of the seven brand-name GLP-1 telehealth providers (Ro, Walgreens, GoodRx, Hims & Hers, PlushCare, Sesame, WeightWatchers) covering true month-one cost, what each dispenses, and how PlexusDx compounded protocols ($129/mo to $349/mo, all-inclusive, no membership) fit when branded coverage isn't accessible.